DOJ investigating UnitedHealth for potential Medicare fraud
Digest more
UnitedHealth Group will stop compensative brokers and sales agents who sell new Medicare Part D prescription drug plans.
UnitedHealth’s stock cuts the Dow’s price by more than 400 points, as care activity accelerates and Medicare costs remain higher than expected.
UnitedHealth has faced several headwinds in the recent past, ranging from a cyberattack, which had greater than initially realized impacts, to the tragic killing of its CEO, which caused the company to suffer harsh public backlash over the company's and industry practices.